BillionToOne, Inc.
NASDAQ:BLLNMedical - Diagnostics & Research
+$0.84 today
- Market cap
- $4.37B
- Beta
- 0.90
- P/E (TTM)
- 182.6
- EPS (TTM)
- $0.55
Volume 1.44M
Average 0.59M
BLLN Common Stock Issued
Cash raised by issuing new shares.
BillionToOne, Inc.NASDAQ: BLLN
Common Stock Issued · Q2 FY2026 · quarter ended Jun 2026
Common stock issued grows 3631.3% year over year
Q2 FY2026 common stock issued of $6.19M rose 3631.3% year over year. Sequentially, it rose 767.5% from the prior quarter.
Context
- Common stock issued amounted to 95.2% of revenue in FY2025, up 9.3 pp from a year earlier.
- Common stock issued increased in 2 of the last 2 fiscal years.
- FY2025 was the highest annual figure in the 3 fiscal years shown.
Sources:Cash FlowText generated from reported figures; not investment advice.
Common Stock Issued history
USD · from the cash flow
- Latest · FY2025
- 290.55M USD
- Year-over-year change
- +121.7%
- 2-year CAGR
- +2458.1%
| Period | Period end | Common Stock Issued | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 290.55M | +121.7% |
| FY2024 | 2024-12-31 | 131.08M | +29422.5% |
| FY2023 | 2023-12-31 | 444K | — |
Common Stock Issued vs competitors
How BLLN compares with its peers on the latest reported figures
- BLLN's LTM Jun 2026 common stock issued of $297.55M is the largest of the 9 companies compared; the peer median is $12.18M.
- Common stock issued amounts to 74.9% of revenue for BLLN, versus a peer median of 2.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
BLLNBillionToOne, Inc. | LTM Jun 2026 | $297.55M | — | — | 74.9% |
| LTM Jun 2026 | $113.61M | — | — | 68.7% | |
| LTM Sep 2026 | $70.38M | +443.1% | — | 5.5% | |
| LTM Jun 2026 | $55.4M | +113.9% | -52.8% | 2.0% | |
| LTM Jun 2026 | $20.47M | — | — | 3.6% | |
WGSGeneDx Holdings Corp. | LTM Jun 2026 | $13.44M | -121.6% | -36.1% | 3.0% |
| LTM Jun 2026 | $3.88M | +138.2% | -57.6% | 0.5% | |
| LTM Mar 2026 | $3.3M | — | — | 0.4% | |
| LTM Mar 2026 | $9K | — | — | 0.0% | |
| Peer median (excluding BLLN) | $12.18M | +126.1% | -52.8% | 2.5% | |
Competitors are the stored peer set for BLLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|
| Net Income | (82.68M) | (41.57M) | 2.92M |
| Depreciation & Amortization | 6.46M | 11.69M | 11.91M |
| Deferred Income Tax | 0 | 0 | 0 |
| Stock-Based Compensation | 4.85M | 8.36M | 15.92M |
| Change in Working Capital | 3.79M | (16.77M) | (22.05M) |
| Accounts Receivables | (2.59M) | (15.62M) | (16.91M) |
| Inventory | (1.41M) | (1.54M) | (8.81M) |
| Accounts Payables | 151K | 877K | 1.78M |
| Other Working Capital | 7.64M | (489K) | 1.89M |
| Other Non-Cash Items | 13.9M | (3.09M) | 15.91M |
| Operating Cash Flow | (53.67M) | (41.38M) | 24.6M |
| Capital Expenditures | (6.17M) | (5.4M) | (8.88M) |
| Acquisitions (Net) | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 |
| Sales of Investments | 90M | 0 | 0 |
| Other Investing Activities | (988K) | (31K) | 0 |
| Investing Cash Flow | 82.84M | (5.43M) | (8.92M) |
| Debt Repayment | 12.96M | 10.48M | (1.73M) |
| Common Stock Issued | 444K | 131.08M | 290.55M |
| Common Stock Repurchased | 0 | (546K) | 0 |
| Dividends Paid | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 0 |
| Financing Cash Flow | 13.41M | 141.02M | 288.83M |
| Effect of Forex Changes | 54.7M | 0 | 0 |
| Net Change in Cash | 97.27M | 94.21M | 304.5M |
| Free Cash Flow | (59.85M) | (46.78M) | 15.71M |
BillionToOne, Inc.
NASDAQ:BLLN
Intrinsic Alpha fair value
Locked
Current Price
$91.54
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.